User:Jarle Pahr/Patents: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
Jarle Pahr (talk | contribs) No edit summary |
Jarle Pahr (talk | contribs) No edit summary |
||
| Line 8: | Line 8: | ||
The effects of business practices, licensing, and intellectual property on development and dissemination of the polymerase chain reaction: case study: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1523369/ | The effects of business practices, licensing, and intellectual property on development and dissemination of the polymerase chain reaction: case study: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1523369/ | ||
The "Lander brief": http://www.americanbar.org/content/dam/aba/publications/supreme_court_preview/briefs-v2/12-398_neither_amcu_lander.authcheckdam.pdf | |||
=Norway= | =Norway= | ||
http://www.lovdata.no/all/nl-19671215-009.html | http://www.lovdata.no/all/nl-19671215-009.html | ||
Revision as of 13:21, 18 June 2013
Notes on patents and IP issues:
Pervasive sequence patents cover the entire human genome
http://www.ipaustralia.com.au/applicant/nucleics-pty-ltd/patents/AU2003285208/
The effects of business practices, licensing, and intellectual property on development and dissemination of the polymerase chain reaction: case study: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1523369/
The "Lander brief": http://www.americanbar.org/content/dam/aba/publications/supreme_court_preview/briefs-v2/12-398_neither_amcu_lander.authcheckdam.pdf
